SCHEMBL7359288

SCHEMBL7359288

Oc1ccc(N2CCNCC2c2ccncc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 2/20 0.45
▸ SLC6A4 P31645 2/20 0.45
▸ SLC6A3 Q01959 2/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPT P10636 2/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ ADRB2 P07550 1/20 0.39
▸ NCF1 P14598 1/20 0.39
▸ PLD1 Q13393 1/20 0.39
▸ HTR2C P28335 6/20 0.37
▸ HTR2B P41595 6/20 0.37
▸ HTR2A P28223 5/20 0.37
▸ RPS6KA3 P51812 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ GSK3B P49841 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9382691 0.90 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3CYP2D6HTR2C
SCHEMBL28112889 0.90 ADRB2 (0.49) SLC6A2SLC6A4SLC6A3CYP2D6L3MBTL1
SCHEMBL7359408 0.84 CYP2D6 (0.45) SLC6A2SLC6A4SLC6A3CYP2D6L3MBTL1
SCHEMBL7366527 0.83 L3MBTL1 (0.63) SLC6A2SLC6A4SLC6A3CYP2D6L3MBTL1
SCHEMBL27491667 0.83 SLC6A2 (0.43) SLC6A2SLC6A4SLC6A3CYP2D6MAPT
SCHEMBL7358923 0.83 CYP2D6 (0.41) SLC6A2SLC6A4SLC6A3CYP2D6L3MBTL1
SCHEMBL6204295 0.82 CYP2D6 (0.43) SLC6A2SLC6A4SLC6A3CYP2D6L3MBTL1
Hydrochloric Acid SCHEMBL7365020 0.82 CYP2D6 (0.41) SLC6A2SLC6A4SLC6A3CYP2D6L3MBTL1
SCHEMBL27504802 0.82 CYP2D6 (0.46) SLC6A2SLC6A4SLC6A3CYP2D6L3MBTL1
SCHEMBL38662188 0.80 SLC6A2 (0.43) SLC6A2SLC6A4SLC6A3CYP2D6ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0825184-B1 Heterocyclic derivatives as platelet aggregation inhibitors ASTRAZENECA AB (SE) 2001-06-20 — — EP disclosed
EP-0691959-B1 HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS ZENECA LTD (GB) 1998-07-22 — — EP disclosed
US-5753659-A ANTICOAGULANTS FOR BLOOD DISORDER, CARDIOVASCULAR DISORDER, THROMBOSIS, ZENECA LIMITED (GB) 1998-05-19 — — US disclosed
US-5750754-A TERTIARY BUTYL 3-METHYL-4-SUBSTITUTED BUTYRATE; CHEMICAL INTERMEDIATES FOR ANTICAOGULANT DRUGS ZENECA LIMITED (GB) 1998-05-12 — — US disclosed
EP-0825184-A1 Heterocyclic derivatives as platelet aggregation inhibitors ZENECA LIMITED (GB) 1998-02-25 — — EP disclosed
US-5563141-A INHIBIT CELL ADHESION FOR EXAMPLE, PLATELET AGGRE GATION ZENECA LIMITED (GB) 1996-10-08 — — US disclosed
CN-1120334-A Heterocyclic derivatives as platelet aggregation inhibitors ZENECA LTD (GB) 1996-04-10 — — CN disclosed
EP-0691959-A1 HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1996-01-17 — — EP disclosed
EP-0690847-A1 HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1996-01-10 — — EP disclosed
WO-1994022835-A2 HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1994-10-13 — — WO disclosed
WO-1994022834-A1 HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1994-10-13 — — WO disclosed
Send feedback